$MDLN News

Medline Inc. (MDLN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Baird Maintains Outperform on Medline, Lowers Price Target to $45

FDA Sends Warning Letter To Medline Over CGMP Violations For Finished Pharmaceuticals On May 28

Barclays Maintains Overweight on Medline, Lowers Price Target to $45

Medline Announces That Medline Canada Has Signed Its First Prime Vendor Agreement In The Country And Is The First Medline Prime Vendor Relationship Outside The United States

Medline Signs Prime Vendor Agreement With Rural Medical Services; Agreement Enables Access To Medline's Medical-Surgical Products And Supply Chain Solution Offerings

Medline Announces Secondary Public Offering Of 60M Shares

BNP Paribas Maintains Neutral on Medline, Lowers Price Target to $40

Tigress Financial Maintains Buy on Medline, Raises Price Target to $62

Citigroup Maintains Buy on Medline, Lowers Price Target to $55

Bernstein Maintains Outperform on Medline, Lowers Price Target to $54

BTIG Reiterates Buy on Medline, Maintains $55 Price Target

Medline Inc. 2026 Q1 - Results - Earnings Call Presentation

Medline Inc. (MDLN) Q1 2026 Earnings Call Transcript

FDA Announces Medline Recalls All Of Its Stock Keeping Units In Medline Branded Neuro Sponge Category With No Definite Market Re-Entry Date

Medline (NASDAQ:MDLN) Q1 Earnings: Revenue Beats, But Profits Slip on Tariff and Cost Pressures

Medline Q1 2026 Earnings Call: Complete Transcript

Medline Q1 EPS $0.33 Beats $0.23 Estimate, Sales $7.400B Beat $7.163B Estimate

FDA Recalls Several Medline Products

Medline Collaborates With Symbotic Over Deployment Of AI Robotics Technology